BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/28/2022 12:37:03 PM | Browse: 791 | Download: 2632
 |
Received |
|
2022-02-06 16:47 |
 |
Peer-Review Started |
|
2022-02-06 16:50 |
 |
First Decision by Editorial Office Director |
|
2022-04-10 08:29 |
 |
Return for Revision |
|
2022-04-10 08:29 |
 |
Revised |
|
2022-05-06 20:18 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-06-06 03:23 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-06-17 21:20 |
 |
Articles in Press |
|
2022-06-17 21:20 |
 |
Edit the Manuscript by Language Editor |
|
2022-06-04 01:43 |
 |
Typeset the Manuscript |
|
2022-10-24 04:25 |
 |
Publish the Manuscript Online |
|
2022-10-28 12:37 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cell Biology |
| Manuscript Type |
Basic Study |
| Article Title |
Expression of the methylcytosine dioxygenase ten-eleven translocation-2 and connexin 43 in inflammatory bowel disease and colorectal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mohammad El-Harakeh, Jessica Saliba, Kawthar Sharaf Aldeen, May Haidar, Layal El Hajjar, Mireille Kallassy Awad, Jana G Hashash, Margret Shirinian and Marwan El-Sabban |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Marwan El-Sabban, PhD, Professor, Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Bliss Street, Beirut 1107, Lebanon. me00@aub.edu.lb |
| Key Words |
Demethylation; Inflammation-induced carcinogenesis; Ulcerative colitis; Colorectal cancer; Connexins |
| Core Tip |
Chronic inflammation of the colon is a risk factor for colorectal cancer. Intestinal inflammation has been associated with reduced gap junction-mediated intercellular communication and downregulation connexins [mainly connexin 43 (Cx43)]. The involvement of the demethylating enzyme ten-eleven translocation-2 (TET-2) (methylcytosine dioxygenase) in the inflammatory process has motivated the investigation of Cx43 and TET-2 expression in colitis and colorectal carcinoma. In vitro and in vivo data report on the upregulation of Cx43 in inflammatory states and a downregulation of TET-2. In human samples of colon adenocarcinoma, both TET-2 and Cx43 were downregulated, potentially implicating them in the malignant transformation of inflamed intestinal tissues. |
| Publish Date |
2022-10-28 12:37 |
| Citation |
El-Harakeh M, Saliba J, Sharaf Aldeen K, Haidar M, El Hajjar L, Awad MK, Hashash JG, Shirinian M, El-Sabban M. Expression of the methylcytosine dioxygenase ten-eleven translocation-2 and connexin 43 in inflammatory bowel disease and colorectal cancer. World J Gastroenterol 2022;28(40): 5845-5864 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i40/5845.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i40.5845 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.